| Entry |
|
|---|
| Name |
Dalteparin sodium (JAN/USP/INN);
Ardeparin sodium;
Fragmin (TN) |
|---|
| Product |
|
|---|
| Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
|
|---|
| Remark |
| Therapeutic category: | 3334 |
| Product (DG00150): | D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US> |
|
|---|
| Efficacy |
Anticoagulant, Antithrombin III activator |
|---|
| Disease |
Deep vein thrombosis [DS: H01723] |
|---|
| Comment |
Low molecular weight heparin (LMWH)
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04610 | Complement and coagulation cascades |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AB Heparin group
B01AB04 Dalteparin
D03353 Dalteparin sodium (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Anticoagulants
Low Molecular Weight Heparins
Dalteparin
D03353 Dalteparin sodium (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
33 Blood and body fluid agents
333 Anticoagulants
3334 Heparins
D03353 Dalteparin sodium (JAN/USP/INN)
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
D03353 Dalteparin sodium
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Organismal systems
Complement and coagulation
SERPINC1 (AT3)
D03353 Dalteparin sodium (JAN/USP/INN) <JP/US>
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01709 Heparin anticoagulant
DG00150 Heparin
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
